Adaptable architecture and modular furniture are fine-tuning spaces to workers’ needs
The difficult reality is a recognition that we will have to spend more and get less than promised from public services
He is an accountant and helps me with my business
Report finds focus on influenza, preparations for no-deal Brexit and ‘groupthink’ strategy hampered response to virus
EU court rules that European Commission unlawfully withheld information about procurement
Employers are failing to meet the eligibility criteria as third party ‘agents’ reap profits, experts warn
Couple’s claim against British Airways sets precedent expected to cost carriers millions of pounds
New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group
Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules
Pharma group dealt another blow following decision by British to award vaccine contract to rival Pfizer
Vaccine maker to seek approval for jab as it tries to diversify product pipeline
Total court-issued penalties for breaches higher than any other crime bar motoring offences and TV licence evasion
Simon Case tells inquiry it was ‘very frustrating’ to work for Boris Johnson during Covid crisis
As Covid revenues slump, technology developed to fight the pandemic is having some success combating this disease
Calls for amnesty intensify as total guilty verdicts over pandemic regulations in England top 27,000
So-called FLiRT strains set to test effectiveness of vaccines against latest mutations
Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals
GSK joins UK government in committing £130mn to tackle growth of antimicrobial resistance
Businesses across hospitality sector have brought dozens of cases in bid to recover some losses
Drugmaker follows Eli Lilly in cutting out middlemen and selling directly to patients
More large-scale investment programmes are possible despite the mixed results of Europe’s post-pandemic plan
Agreement worth up to $1.2bn includes plan for combined flu and Covid shots
Saving humanity’s a costly business
Also in this newsletter: UK expels Russian defence attaché for spying, Toyota profits drop 20%, regulatory costs hit Uber